Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...

† Department of Biomedical Engineering, McGill University, Room 316, Duff Medical Building, 3775, rue University, Montréal, QC H3A 2B4, Canada ‡ McGill University Genome Quebec Innovation Centre, 740 ...

Lugano, 4 December 2025 – The ESMO Immuno-Oncology Congress 2025 will take place from 10–12 December in London, UK, bringing together specialists in cancer immunotherapy to present and discuss ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

The Conference Forum today announced the launch of the 12th annual Immuno-Oncology 360º Summit (IO360°) taking place February 10-12, 2026, at the Sheraton Boston Hotel in Boston, MA. “IO360º provides ...

An MUSC spinoff company is already helping difficult-to-treat cancer patients and has shown it can create a therapy that is far cheaper and has fewer side effects than what is currently available. But ...

Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking research in ...

Through its re-upped pact with AstraZeneca, Immunai is slated to receive $18 million for the first phase of the new project. (wildpixel/Getty Images) AstraZeneca is extending its work with Immunai ...

Aug 12 (Reuters) - Pfizer (PFE.N), opens new tab said on Monday its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults ...

An international research team led by the University of Vienna has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can ...

According to recent study by nova one advisor, the global immuno-oncology (IO) market size was estimated at USD 43.73 billion in 2023 and is projected to hit around USD 284.29 billion by 2033, growing ...

A phase 2a study of NT-I7 (efineptakin alfa), a long-acting IL-7, and pembrolizumab to evaluate efficacy, including overall survival, in hard-to-treat gastrointestinal tumors. This is an ASCO Meeting ...